Al Shaar A, Hamadeh O, Ali A
Medicine (Baltimore). 2025; 103(52):e41072.
PMID: 39969370
PMC: 11688012.
DOI: 10.1097/MD.0000000000041072.
Mendez Lopez L, Gonzalez Llerena J, Vazquez Rodriguez J, Medellin Guerrero A, Gonzalez Martinez B, Solis Perez E
Nutrients. 2025; 16(24.
PMID: 39770983
PMC: 11676904.
DOI: 10.3390/nu16244363.
Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y
Mol Cancer. 2024; 23(1):261.
PMID: 39574178
PMC: 11580516.
DOI: 10.1186/s12943-024-02165-x.
Han R, Su L, Cheng L
Vaccines (Basel). 2024; 12(9).
PMID: 39340042
PMC: 11436046.
DOI: 10.3390/vaccines12091012.
Boehm T
Nat Rev Immunol. 2024; 25(2):141-152.
PMID: 39317775
DOI: 10.1038/s41577-024-01083-9.
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.
Seefeld M, Templeton E, Lehtinen J, Sinclair N, Yadav D, Hartwell B
Front Immunol. 2024; 15:1419527.
PMID: 39286244
PMC: 11403286.
DOI: 10.3389/fimmu.2024.1419527.
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z
Signal Transduct Target Ther. 2024; 9(1):225.
PMID: 39198425
PMC: 11358547.
DOI: 10.1038/s41392-024-01947-5.
Deciphering the spatiotemporal transcriptional landscape of intestinal diseases (Review).
Guo Y, Ren C, He Y, Wu Y, Yang X
Mol Med Rep. 2024; 30(3).
PMID: 38994768
PMC: 11258600.
DOI: 10.3892/mmr.2024.13281.
Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer.
Xu Z, Wang Q, Zhang Y, Li X, Wang M, Zhang Y
Front Oncol. 2024; 14:1383096.
PMID: 38846981
PMC: 11153738.
DOI: 10.3389/fonc.2024.1383096.
Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review.
Perera J, Delrosso C, Nerviani A, Pitzalis C
Cells. 2024; 13(9.
PMID: 38727279
PMC: 11083059.
DOI: 10.3390/cells13090743.
Tertiary lymphoid structures in head and neck squamous cell carcinoma.
Zhu J, Lu H, Wang K, Liu B, Yan J
Transl Oncol. 2024; 44:101949.
PMID: 38583352
PMC: 11391034.
DOI: 10.1016/j.tranon.2024.101949.
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications.
Wang S, Wang H, Li C, Liu B, He S, Tu C
MedComm (2020). 2024; 5(3):e489.
PMID: 38469550
PMC: 10925885.
DOI: 10.1002/mco2.489.
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
Vahidian F, Lamaze F, Bouffard C, Coulombe F, Gagne A, Blais F
Cancers (Basel). 2024; 16(4).
PMID: 38398098
PMC: 10887067.
DOI: 10.3390/cancers16040708.
Tertiary lymphoid structures in autoimmune diseases.
Dong Y, Wang T, Wu H
Front Immunol. 2024; 14:1322035.
PMID: 38259436
PMC: 10800951.
DOI: 10.3389/fimmu.2023.1322035.
A Metabolic Axis of Immune Intractability.
Hinshaw D, Patel M, Shevde L
Cancer Immunol Res. 2023; 12(3):282-286.
PMID: 38126910
PMC: 10936744.
DOI: 10.1158/2326-6066.CIR-23-0433.
Heterogeneity of tertiary lymphoid structures in cancer.
You X, Koop K, Weigert A
Front Immunol. 2023; 14:1286850.
PMID: 38111571
PMC: 10725932.
DOI: 10.3389/fimmu.2023.1286850.
Delivery of nucleic acids using nanomaterials.
Qin Y, Ou L, Zha L, Zeng Y, Li L
Mol Biomed. 2023; 4(1):48.
PMID: 38092998
PMC: 10719232.
DOI: 10.1186/s43556-023-00160-0.
Protective fibroblastic niches in secondary lymphoid organs.
De Martin A, Stanossek Y, Pikor N, Ludewig B
J Exp Med. 2023; 221(1).
PMID: 38038708
PMC: 10691961.
DOI: 10.1084/jem.20221220.
Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
Shen C, Zhang D, Cheng X, Zhang W, Zhao J
Urol Int. 2023; 107(9):841-847.
PMID: 37769625
PMC: 10623398.
DOI: 10.1159/000532127.
Transcription factor TCF-1 regulates the functions, but not the development, of lymphoid tissue inducer subsets in different tissues.
Zheng M, Yao C, Ren G, Mao K, Chung H, Chen X
Cell Rep. 2023; 42(8):112924.
PMID: 37540600
PMC: 10504686.
DOI: 10.1016/j.celrep.2023.112924.